Study examines use of clinical and cost-effectiveness data for drug coverage decisions
Tuesday, October 6, 2009 - 16:14
in Health & Medicine
A comparison of national agencies that play a role in determining drug coverage decisions in Britain, Canada and Australia finds that uncertainty regarding clinical effectiveness is a key issue in coverage decisions, with other factors including the ability to negotiate price and societal values, according to a study in the October 7 issue of JAMA.